Cross-sectional associations between human papillomavirus (HPV), anal squamous intraepithelial lesions (SIL), and human immunodeficiency virus (HIV) were studied in a cohort of gay men. HPV DNA was detected by generic and type-specific polymerase chain reaction (PCR) probes and hybrid capture assay (HC). HPV virus load was estimated by HC relative light unit (RLU) ratio. HPV prevalence, number of HPV types detected, and HC RLU ratios were each greater in HIV-positive than HIV-negative participants. Further, among HIV-positive men, HC RLU ratio was inversely associated with CD4 cell count. SIL was more frequent in HIV-positive participants, particularly those with a CD4 cell count õ200/mL and was positively associated with HPV. Men with a high HC RLU ratio were nearly 3 times more likely to have SIL than were those both PCR-and HC-negative. These data support that HIV augments HPV-associated anal disease in this population.
Human papillomaviruses (HPV), particularly that in the general population [10] . While that study could not assess the risk associated with HIV independently from -18, are causally associated with invasive cervical cancer and its precursors [1 -4] . Since the squamocolumnar junction bethat associated with homosexuality, cross-sectional studies have demonstrated both an increased prevalence of anal HPV tween the rectum and anus are histologically similar to the transformation zone of the uterine cervix, attention has been infection and of SIL among HIV-seropositive men, particularly those who are symptomatic or have decreased CD4 cell focused on the role of HPV in anal carcinoma [4] . HPV DNA sequences have been detected in anal canal tumors and in their counts [11, 12] . HPV DNA has been detected in 78% of HIV-seronegative putative precursors, squamous intraepithelial lesions (SIL) [4] . In a case-control study comparing anal cancer specimens with (HIV-negative) and 92% of HIV-seropositive (HIV-positive) men using the sensitive polymerase chain reaction (PCR) assay those from rectal adenocarcinomas, HPV DNA was detected in 84% of the former and none of the latter [5] . [11] , while less-sensitive methods have detected HPV infection in 6% -38% of the former and 26% -64% of the latter [11 -Although anal cancer is rare among men in general, gay men who practice receptive anal intercourse appear to be at 15] . In a prospective study of 305 gay or bisexual men, 5% of HIV-negative and 15% of HIV-positive participants developed increased risk for this neoplasm [6 -8] . In addition, concomitant infection with human immunodeficiency virus (HIV), high-grade SIL. The risk of SIL among HIV-positive men was associated with high levels of HPV-16 or -18 and with dewhich is prevalent in gay men, may facilitate and/or accelerate the pathologic consequences of HPV infection in the anus pressed CD4 cell counts [16] . In addition, the incidence of anal SIL among HIV-negative men with high levels of these HPV as has been shown for the cervix [9] . In a population-based study linking AIDS and cancer registries, the risk of anal types was similar to that previously reported for cervical neoplasia in HIV-negative women. cancer among persons with AIDS was 84 times greater than We undertook the current study to estimate the prevalence of HPV and SIL in a well-established and characterized cohort of gay men, to examine whether associations between HPV (SHARE) were eligible for the present study. SHARE, one of four probe A hybridizes to the low-risk HPV-6, -11, -42, -43, and  -44, while probe B hybridizes to the intermediate-and high-risk  sites participating in the Multicenter AIDS Cohort Study, enrolled  men from October 1984 to April 1985, and reopened enrollment  HPV-16, -18, -31, -33, -35, -45, -51, -52 , and -56. The number of relative light units (RLUs) for each specimen was divided by in 1988 to increase participation from minority populations. As described in detail elsewhere, SHARE followed gay and bisexual the number from an appropriate positive control, and RLU ratios õ1.0 were considered negative for the targeted HPV DNA. RLUs men at semiannual visits to investigate the natural history of HIV infection and AIDS [17, 18] . At baseline and at each semiannual are proportional to the amount of targeted DNA in the specimen so that greater ratios indicate greater numbers of DNA copies. visit, participants completed a detailed standardized intervieweradministered questionnaire on demographics, behavioral, and med-PCR amplification of HPV DNA sequences was performed using MY09/MY11/HMB01 L1 consensus primers [22, 23] . Products ical events, underwent a focused physical examination, and provided biologic specimens. All eligible HIV-positive men and a were hybridized individually to type-specific probes to HPV-6, -11, -16, -18, -31, -33, -35, -39, -40, -45, -51, -52, -53, -54, -55, subset of eligible HIV-negative men were provided with information about the present study and invited to participate.
-56, -58, -59, -66, -68, and -73; unnumbered types PAP155, PAP291, and w13b; and to a generic probe capable of detecting almost all genital HPVs. Hybridization signal strength was coded Specimen Collection 0-4 for the generic and each type-specific probe; a signal strength of 0 indicates an absence of the targeted HPV DNA, while codes At each SHARE visit, participants had blood drawn for T cell 1-4 indicate increasing signal intensity. In addition, for each speciphenotyping and detection of HIV antibody, as indicated. In addimen, human b-globin DNA was amplified and hybridized as a tion, at each visit during the study period, 2 anal specimens were test of the specimen's suitability for amplification of HPV DNA collected by inserting a saline-moistened Dacron swab into the sequences. Specimens from which viral DNA was detected were anal canal beyond the pectinate line and rotating it several times considered adequate for amplification, regardless of whether bagainst the anorectal wall. The first swab, an anal epithelial cell globin DNA was detected, while specimens from which no HPV specimen, was used for the detection of cytologic abnormalities.
DNA and no b-globin DNA could be detected were considered Cytology specimens obtained from November 1992 to July 1993 nonamplifying and thus inadequate for detection of HPV DNA. were prepared by conventional smear methodology. However, beParticipants with nonamplifying specimens were excluded from cause a large proportion were unsatisfactory for diagnostic interanalyses of HPV infection. pretation, these are not included in the present study [19] . Swabs collected after July 1993 were placed in fluid (Cytolite; CYTYC, Boxborough, MA) and subsequently processed as single thin-layer HPV DNA Analyses slides (ThinPrep; CYTYC) as described in the manufacturer's in-HPV detection by PCR was considered for individual DNA structions. The second anal swab was placed into a tube containing types, any DNA type, total number of DNA types, and HPV types normal saline and frozen at 070ЊC until processed for detection grouped in risk categories based on their association with cervical of HPV DNA.
cancer [1, 24, 25] . For these analyses the low-risk category included HPV-6, -11, -40, -53, -54, -55, and -66, and PAP155 and PAP291; intermediate risk included HPV-33, -35, -39, -51, -52, Laboratory Methods -56, -58, -59, -68, and -73 and w13b; and high risk included HPV-HIV testing and lymphocyte phenotyping. Serum collected at 16, -18, -31, and -45. In addition, a crude measure of virus load each study visit was tested by ELISA in blinded fashion for antiwas made separately for each risk category by summing the indibody to HIV, and standard techniques were used to determine vidual PCR signal strengths for each of the HPV types present in CD4 cell counts. Details of laboratory procedures are described each specimen included in that risk category. For HC, each specielsewhere [17, 18] . men was scored positive or negative for probes A and B, and the Cytologic diagnosis. The thin-layer slides were stained with a RLU ratio of the specimen was used to estimate virus load. The modified Papanicolaou procedure and diagnosed according to the association of SIL with virus load was also examined using a Bethesda System [20] by two independent reviewers. Discrepancombination PCR/HC variable. The analytic sensitivity of HC is cies in the initial readings were adjudicated in joint review by on the order of Ç100,000 genome copies compared with 10-100 the 2 pathologists at a multihead microscope. Abnormalities of copies for PCR. Thus, with specimens negative for both assays squamous intraepithelial cells were diagnosed as atypical squaserving as a referent group, HC-positive specimens (regardless of mous cells of undetermined significance or SIL. The latter were PCR results) were considered to have high virus loads, and PCRfurther classified as low-grade SIL (mild dysplasia) or high-grade positive HC-negative specimens were considered to have interme-SIL (moderate or severe dysplasia or carcinoma in situ). Slides diate virus load. HC-positive specimens were further distinguished were considered inadequate if õ10% of the specimen area was as those with a probe RLU ratio ú5.0 or those with both probe covered with nucleated cells.
RLU ratios between 1.1 and 5.0. Detection and typing of HPV DNA. Specimens were screened for HPV DNA by two methods: the FDA-approved, tube-based Statistical Methods HC (Digene Diagnostics, Silver Spring, MD) and PCR amplification. HC methods are described in detail elsewhere [21] . Briefly, Fisher's exact test was applied to comparisons of two proportions, and linear trends in proportions were assessed by a x 2 statisspecimens were hybridized to two HPV RNA probe cocktails; / 9d4a$$jy34 06-02-98 12:54:47 jinfas UC: J Infect by both methods in 49 specimens. HPV DNA was detected by PCR only in 22 specimens, and by HC only in 4 (3 of which were PCR-positive for one or more HPV types not contained Results in HC probe B). In addition, HC positivity was significantly Population Characteristics associated with virus load as crudely measured by summed PCR signal strengths to the HPV types included in probe B Men who attended at least one study visit between November (figure 1). HC probe B positivity ranged from 8% among 49 1992 and January 1994 were asked to participate in the present specimens negative by PCR for each of the HPV types to 95% study by providing anal specimens for the detection of HPV among 20 specimens with summed PCR signal strengths of DNA and cytologic abnormalities. By design, HIV-positive §8 (x 2 for trend, P õ .001). men were overrepresented in the final study population; 184 HPV associated with HIV and CD4 cell count. HPV was (72%) of 256 HIV-positive and 79 (46%) of 171 HIV-negative highly prevalent among study participants, with 90% of HIVattendees participated. Participants were similar to nonparticipositive and 70% of HIV-negative men positive to the generic pants with respect to age (37% õ40 years), race (13% black), PCR probe (Fisher's exact test, P õ .002) (table 1) . With and number of male partners in the previous 6 months (27% the type-specific probes, a broad spectrum of HPV types was none, 10% ú6). 
HPV virus load associated with HIV and CD4 cell count.
Low risk 6 17 (13) 5 (11) The hypothesis that HPV is not only more common but present 26 (19) 4 (9) was tested by comparing HC probe B RLU ratios among parti-
cipants known to be HPV-positive (table 2) . Among partici- (21) 14 (30) men with CD4 cell counts õ200/mL compared with those with 2 34 (25) 5 (11) greater CD4 cell counts (Wilcoxon rank sum test, P õ .07). terns similar to those seen with total RLU ratio (data not ‡ Wilcoxon rank sum test for total number of types detected in HIV-positive shown).
vs. HIV-negative participants.
Cytologic Findings
SIL associated with HIV. Liquid-based anal cytology specpants (RR Å 1.7; 95% CI, 1.2 -2.2). HPV was detected by HC probe A and HC probe B, respectively, in 30% and 50% of imens were collected from 69 (84%) of 79 HIV-negative and 122 (66%) of 184 HIV-positive participants. Of these, 54 (78%) 112 HIV-positive men compared with 8% and 10% of 62 HIVnegative men. Thus, HIV-positive participants were nearly 4 from HIV-negative and 102 (84%) from HIV-positive participants were adequate for cytologic diagnosis. The remaining 33 times more likely to be positive by HC probe A (RR Å 3.8; 95% CI, 1.6 -9.1) and 5 times more likely to be positive by slides were unsatisfactory: 21 had insufficient cellularity, 11 consisted mainly of anucleated squamous cells, and 1 was test, P ú .2). Mean CD4 cell count among the 40 participants with normal cytology was 469 { 319 cells/mL compared with poorly preserved.
Abnormal anal cytology was common among study partici-402 { 292 cells/mL among 20 with atypical squamous cells of undetermined significance and 363 { 286 cells/mL among pants and was positively associated with HIV infection (table  3) . Overall, 41% of HIV-positive compared with 17% of HIV-42 with SIL (Kruskal-Wallis test, P ú .2). There was also a weak association between SIL and time since HIV seroconvernegative participants had SIL (RR Å 2.5; 95% CI, 1.3 -4.7), and the only two high-grade (AIN II) lesions detected ocsion; among 21 participants who acquired HIV during followup, 9 seroconverters with SIL had been HIV-positive an avercurred in HIV-positive men. The prevalence of SIL increased with decreasing CD4 cell count (x 2 for trend, P Å .002); age of 6.8 years, while 12 without SIL had been infected an average of 5.2 years (Wilcoxon rank sum test, P Å .13). however, when confined to HIV-positive participants, this association did not reach statistical significance (Fisher's exact SIL associated with HPV. SIL was positively associated with HPV infection as detected by PCR, HC, and a combined PCR/HC variable (table 3). The prevalence of SIL increased with increasing number of HPV types detected by PCR (x 2 for trend P Å .025). However, there was no evidence that this variable, men with HC probe A and/or B RLU ratios ú5.0 were nearly three times more likely to have SIL than were £1.0 13 (19) 9 (60) 1 (5) 12 (25) those both PCR-and HC-negative.
1.1 -2.0 16 (23) 2 (13) 3 (14) 13 (27) High-grade SIL was detected in 2 participants; one was PCR-2.1 -3.0 6 (9) 0 2 (10) 4 (8) positive for HPV-16 alone and negative to both HC probes, virus load could be explained by HIV or other potential con-HIV-negative participants.
founders. The association of SIL with the combined PCR/HC ‡ Wilcoxon rank sum test for HC probe B RLU ratio in HIV-positive participants with CD4 cell count õ200 vs. §200/mL. examination, and number of male partners in the previous 6 Among men PCR-positive for the viral types included in HC probe B, RLU ratios were greater among those with HIV than months. Similarly, when limited to HIV-positive participants, in those who were HIV-negative. Further, among HIV-positive the PCR/HC variable remained associated with SIL when admen, HC RLU ratios were greater in those with CD4 cell counts justed for CD4 cell count, age, and number of partners. Further, õ200/mL. Given the high rate of detection by PCR of HPV in none of these covariates was independently associated with HIV-negative men, these findings suggest that preexistent HPV SIL.
infection is reactivated or up-regulated by the immunosuppression that is a hallmark of HIV infection. Analogously, a low CD4 cell count is a risk factor for repeated detection of cervical Discussion HPV in HIV-infected women [30, 31] . HIV may also affect In this cross-sectional examination of a cohort of gay men, HPV expression by molecular interaction between the two viwe found HPV and SIL to be common and to be associated ruses [32] . with HIV. The greater prevalence of HPV among HIV-positive It has been hypothesized that the effect of HIV on HPV men was more pronounced by HC probe A (RR Å 3.8; 95%
infection will lead to an increased incidence of anal cancer in CI, 1.6 -9.1) and probe B (RR Å 5.2; 95% CI, 2.4 -11.4) than men infected with both viruses. The results of this and other by PCR (RR Å 1.7; 95% CI, 1.2 -2.2). Since the analytic cross-sectional studies support this hypothesis [11 -15, 33] . In sensitivity of HC is low relative to PCR, this suggests that our study population, anal cytologic abnormalities were more HPV is present in greater amounts in individuals coinfected frequent in HIV-positive men, particularly those with CD4 cell with HIV. Southern or dot blot positivity in PCR-positive specicounts õ200/mL. As in other cross-sectional studies, highmens has been used as an indication of high HPV virus load grade SIL, the putative precursor to anal carcinoma, was rare, in previous studies [11, 13] . By using hybrid capture, which and the low-grade lesions we observed were not selectively utilizes chemiluminescent detection, we were able to estimate associated with high-risk HPV types [11 -15, 33] . Rather, SIL was most common among men infected with multiple HPV HPV virus loads more directly and on a continuous scale.
/ 9d4a$$jy34
06-02-98 12:54:47 jinfas UC: J Infect types or who were infected at levels detectable by HC, regardclinical significance of the spectrum of anal lesions and the utility of HPV DNA and cytologic testing to detect lesions that less of viral type. To date, a single prospective study has compared the incidence of SIL in HIV-positive to that in HIVrequire intervention. negative men [16] . In that study, high-grade SIL was nearly 3 times more likely to develop in HIV-positive participants. Higher levels (i.e., detection by Southern transfer hybridiza-
